2023/02/08 21:00:35 | |
---|---|
Price | |
110.249 USD | |
Difference | -1.55% (-1.74) |
ISIN | US0028241000 |
Symbol | ABT |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 181,995 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 110.23 USD (300) |
Ask (Ask size) | 110.26 USD (200) |
Open | 111.40 USD |
High | 111.87 USD |
Low | 110.08 USD |
Close (prev. day) | 111.99 USD |
VWAP | 110.636612 USD |
Volume (pcs) | 2,395,201 |
Trading volume | 265,045,031.40 |
Number of trades | 29,059 |
Last size | 100 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2023/02/07 |
![]() |
Global Equity Ratings |
![]() |
2023/01/30 |
![]() |
Global Equity Ratings |
![]() |
2023/01/09 |
![]() |
Global Equity Ratings |
![]() |
2022/12/19 |
![]() |
Global Equity Ratings |
![]() |
2022/11/28 |
![]() |
Global Equity Ratings |
![]() |
2023/02/08 21:00:35 | |
---|---|
Price | |
110.249 USD | |
Difference | -1.55% (-1.74) |
ISIN | US0028241000 |
Symbol | ABT |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 181,995 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 110.23 USD (300) |
Ask (Ask size) | 110.26 USD (200) |
Open | 111.40 USD |
High | 111.87 USD |
Low | 110.08 USD |
Close (prev. day) | 111.99 USD |
VWAP | 110.636612 USD |
Volume (pcs) | 2,395,201 |
Trading volume | 265,045,031.40 |
Number of trades | 29,059 |
Last size | 100 |
6m | 1Y | 3Y | |
Perf (%) | -2.74% | -6.74% | +30.14% |
Perf (abs.) | -2.94 | -7.55 | +24.18 |
Beta | 0.80 | 0.83 | 0.81 |
Volatility | 21.47 | 24.45 | 29.76 |
Ø price 5 days | Ø volume 5 days (pcs.) | 111.720 USD (4,177,170) |
Ø price 30 days | Ø volume 30 days (pcs.) | 111.322 USD (4,632,809) |
Ø price 100 days | Ø volume 100 days (pcs.) | 105.281 USD (5,488,185) |
Ø price 250 days | Ø volume 250 days (pcs.) | 110.026 USD (5,289,437) |
YTD High | date | 115.690 USD (2023/01/11) |
YTD Low | date | 108.750 USD (2023/01/03) |
52 Weeks High | date | 130.790 USD (2022/02/09) |
52 Weeks Low | date | 93.250 USD (2022/10/21) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/02/08 | 17:35 | 103.24 EUR | 0.08 | 22 |
Vienna Stock Exchange | 2023/02/08 | 17:32 | 103.24 EUR | 0.00 | 2 |
Tradegate | 2023/02/08 | 20:41 | 102.72 EUR | 0.06 | 17 |
Stuttgart | 2023/02/08 | 08:07 | 103.92 EUR | 0.00 | 1 |
SIX Swiss Exchange | 2023/01/16 | 17:30 | 103.00 CHF | 0.00 | 1 |
NYSE | 2023/02/08 | 21:00 | 110.249 USD | 265.05 | 29,059 |
Munich | 2023/02/08 | 18:20 | 102.74 EUR | 0.01 | 2 |
London Stock Exchange | 2023/02/08 | 13:03 | 111.99 USD | 36.43 | 7 |
Hanover | 2023/02/08 | 08:17 | 103.96 EUR | 0.00 | 1 |
Hamburg | 2023/02/08 | 10:16 | 103.74 EUR | 0.06 | 2 |
Frankfurt | 2023/02/08 | 13:49 | 104.04 EUR | 0.01 | 3 |
Duesseldorf | 2023/02/08 | 18:31 | 102.42 EUR | 0.00 | 11 |
Berlin | 2023/02/08 | 20:31 | 102.86 EUR | 0.00 | 17 |
BX Swiss | 2023/02/03 | 18:00 | 102.692 CHF | 0.00 | 1 |
ABBOTT LABORATORIES |
- - |
100 Abbott Park Road - 60064-6400 Abbott Park |
Telefon: 1-224-667-6100 |
Fax: - |
E-mail: - |
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL. |
Robert Alpern | Member of Board of Directors |
Sally Blount | Member of Board of Directors |
Claire Babineaux-Fontenot | Member of Board of Directors |
Daniel Starks | Member of Board of Directors |
Darren McDew | Member of Board of Directors |
Glenn Tilton | Member of Board of Directors |
John Stratton | Member of Board of Directors |
Michael Roman | Member of Board of Directors |
Michelle Kumbier | Member of Board of Directors |
Nancy McKinstry | Member of Board of Directors |
Paola Gonzalez | Member of Board of Directors |
William Osborn | Member of Board of Directors |
Robert Ford | Chairman of Managing Board |
Gene Huang | Member of Executive Committee |
John Capek | Member of Executive Committee |
Andrea Wainer | Member of Executive Committee |
Daniel Gesua Sive Salvadori | Member of Executive Committee |
David Mark | Member of Executive Committee |
Hubert Allen | Member of Executive Committee |
Jim Leffelman | Member of Executive Committee |
Karen Chayavirabood | Member of Executive Committee |
Karen Peterson | Member of Executive Committee |
Kathryn Collins | Member of Executive Committee |
Lisa Earnhardt | Member of Executive Committee |
Mary Moreland | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer